Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
…
continue reading
In this audio interview conducted on October 30, 2024, the editors are joined by the Minister of Health of Rwanda to discuss both actions taken to halt the spread of disease and the use of experimental vaccines and therapies. Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Sabin Nsanzimana, M.D., P…
…
continue reading
1
NEJM Interview: Vincent Guilamo-Ramos on the need to rethink the response to HIV in Latino communities.
7:13
7:13
Play later
Play later
Lists
Like
Liked
7:13
Vincent Guilamo-Ramos is the executive director of the Institute for Policy Solutions at the Johns Hopkins School of Nursing. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. V. Guilamo-Ramos, M. Thimm-Kaiser, and A. Benzekri. The U.S. Latino HIV Crisis — Ending an Era of Invisibility. N Engl J Med 2024;391:1665-…
…
continue reading
1
NEJM Interview: Liam McCoy on concerns about the implementation of large language models in note writing and related clinical tasks.
13:41
13:41
Play later
Play later
Lists
Like
Liked
13:41
Liam McCoy is a resident physician in neurology at the University of Alberta. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.G. McCoy, A.K. Manrai, and A. Rodman. Large Language Models and the Degradation of the Medical Record. N Engl J Med 2024;391:1561-1564.
…
continue reading
1
NEJM Interview: Mark Wicclair on approaches to protecting both physicians’ conscience and patients’ health.
8:02
8:02
Play later
Play later
Lists
Like
Liked
8:02
Mark Wicclair is an adjunct professor of medicine at the University of Pittsburgh Center for Bioethics and Health Law and a professor of philosophy emeritus at West Virginia University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.B. White and M. Wicclair. Navigating Clinicians’ Conscience-Based Refusals to…
…
continue reading
1
NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.
21:26
21:26
Play later
Play later
Lists
Like
Liked
21:26
Jose Figueroa is an associate professor of health policy and management at the Harvard T.H. Chan School of Public Health and an assistant professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. McWilliams and S.B. Dusetzina. Affordability of Health Care in the United…
…
continue reading
1
NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern.
9:20
9:20
Play later
Play later
Lists
Like
Liked
9:20
Jean Nachega is an associate professor of infectious diseases and microbiology and of epidemiology at the University of Pittsburgh School of Public Health and a professor of medicine at Stellenbosch University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.B. Nachega and Others. Mpox in Pregnancy — Risks, Ve…
…
continue reading
1
NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform.
8:47
8:47
Play later
Play later
Lists
Like
Liked
8:47
Jonathan Oberlander is a professor of social medicine and of health policy and management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Oberlander. Health Care Reform and the 2024 U.S. Elections — Low Visibility, High Stakes. N Engl J Med 2024;391:1169-117…
…
continue reading
1
NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions.
10:12
10:12
Play later
Play later
Lists
Like
Liked
10:12
Abigail Cutler is an assistant professor and associate residency program director in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Cutler and E. Hartenbach. Dobbs Revisited — Addressing Effects…
…
continue reading
1
NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs.
11:56
11:56
Play later
Play later
Lists
Like
Liked
11:56
Charles Weijer is a professor in the Departments of Medicine and Philosophy at Western University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C. Weijer and M. Taljaard. Ethical Challenges Associated with Pragmatic and Cluster RCTs. N Engl J Med 2024;391:969-971.…
…
continue reading
1
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
2:58
2:58
Play later
Play later
Lists
Like
Liked
2:58
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors
2:56
2:56
Play later
Play later
Lists
Like
Liked
2:56
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
3:11
3:11
Play later
Play later
Lists
Like
Liked
3:11
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer
3:23
3:23
Play later
Play later
Lists
Like
Liked
3:23
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
3:25
3:25
Play later
Play later
Lists
Like
Liked
3:25
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
3:41
3:41
Play later
Play later
Lists
Like
Liked
3:41
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
3:44
3:44
Play later
Play later
Lists
Like
Liked
3:44
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer
2:50
2:50
Play later
Play later
Lists
Like
Liked
2:50
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer
2:21
2:21
Play later
Play later
Lists
Like
Liked
2:21
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Ponsegromab in Cancer Cachexia
2:37
2:37
Play later
Play later
Lists
Like
Liked
2:37
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM Interview: Benjamin Chrisinger on proposed changes to the Supplemental Nutrition Assistance Program and other options for promoting improved health.
9:11
9:11
Play later
Play later
Lists
Like
Liked
9:11
Benjamin Chrisinger is an assistant professor in the Department of Community Health at Tufts University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. B.W. Chrisinger. Keeping SNAP in Line with Global Evidence on Food Security. N Engl J Med 2024;391:873-875.
…
continue reading
1
NEJM Interview: Erin Fuse Brown on the potential implications of recent Supreme Court decisions for health law and policy.
12:24
12:24
Play later
Play later
Lists
Like
Liked
12:24
Erin Fuse Brown is a professor of health services, policy, and practice at the Brown University School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.E. Sachs and E.C. Fuse Brown. Supreme Power — The Loss of Judicial Deference to Healt…
…
continue reading
1
NEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2:51
2:51
Play later
Play later
Lists
Like
Liked
2:51
Did you miss the ESC Congress 2024? In a series of audio interviews (featured below), Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESC — Asundexian versus Apixaban in Patients with Atrial Fibrillation
3:48
3:48
Play later
Play later
Lists
Like
Liked
3:48
Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction
3:28
3:28
Play later
Play later
Lists
Like
Liked
3:28
Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Have a listen! Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction
3:12
3:12
Play later
Play later
Lists
Like
Liked
3:12
Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
4:08
4:08
Play later
Play later
Lists
Like
Liked
4:08
Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading